Article Information
History
- October 11, 2022.
Article Versions
- You are currently viewing Version 1 of this article (October 11, 2022 - 14:42).
- Version 2 (November 11, 2022 - 06:01).
- Version 3 (March 7, 2023 - 08:13).
- Version 4 (October 11, 2023 - 13:37).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- A. Parker Ruhl1,2,*,
- Jarrett M. Jackson1,
- Carlos J. Carhuas1,
- Jessica G. Niño de Rivera1,
- Michael P. Fay3,
- J. Brice Weinberg4,
- Loretta G. Que5 and
- Hans C. Ackerman1
- 1Physiology Unit, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States
- 2Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States
- 3Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States
- 4Department of Medicine and Division of Hematology, Duke University School of Medicine and Durham VA Medical Centers, Durham, NC, United States
- 5Department of Medicine and Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine and Durham VA Medical Centers, Durham, NC, United States
- ↵*Corresponding author: Dr. A. Parker Ruhl, MD, MHS, Building 10-Clinical Research Center, Rm. B3-4207, 10 Center Dr., Bethesda MD, 20892-1684, parker.ruhl{at}nih.gov, Tel: 240-669-5776, Fax: 301-480-0590
Author contributions: All listed authors meet ICJME recommendations for authorship criteria, including substantial contributions to the conception or design of the work (A.P.R., H.C.A., L.G.Q., J.B.W.); or the acquisition, analysis, or interpretation of data for the work (A.P.R., H.C.A., J.M.J., C.J.C., J.G.N., M. P. F., L.G.Q.); Drafting the work (A.P.R.) or revising it critically for important intellectual content and final approval of the version to be published (All).
Posted October 11, 2022.
